Participants 79 107 4
metastatic colorectal cancer
Participants 225 288 6
patients with metastatic colorectal cancer (mCRC) for treatment
Participants 446 674 7
A selection of 17 polymorphisms in genes encoding drug targets, pathway molecules and detoxification enzymes was analyzed in 279 previously untreated mCRC patients treated with capecitabine, oxaliplatin and bevacizumab (CAPOX-B)
Participants 1469 1482 6
mCRC patients
